DEEP DIVE

MOTS-c

What is MOTS-c peptide?

MOTS-c is a peptide made of 16 amino acids. Its genetic instructions are found in mitochondria, the parts of cells involved in energy production. Researchers study its role in energy use and responses to stress.

Last updated: 2026-10-08

At a Glance

Full Name: Mitochondrial ORF of the 12S rRNA type-c

Abbreviation: MOTS-c

Class: Mitochondrial-derived peptide (MDP)

Sequence: MRWQEMGYIFYPRKLR (16 amino acids)

Encoded By: 12S rRNA gene within mitochondrial DNA

Discovery: 2015 — Lee et al., Cell Metabolism

Primary Pathway: Folate → AICAR → AMPK activation

Key Organ Target: Skeletal muscle (primary), systemic

Exercise Induction: 11.9-fold increase in skeletal muscle after acute exercise

Clinical Stage: Preclinical / Early clinical (NCT03998514)

IN THIS ARTICLE

Why is MOTS-c studied?How does MOTS-c work in research models?The Exercise Mimetic: What the Research Shows MOTS-c and Aging: The Longevity Connection MOTS-c vs. Other Longevity & Metabolic Peptides Current Challenges and Research Frontiers FAQ References

Why is MOTS-c studied?

MOTS-c helped expand research on mitochondrial signals. Mitochondria are best known for their role in making usable cellular energy. They also contain genetic information.

The peptide belongs to a group called mitochondrial-derived peptides. These are short molecules associated with mitochondrial genetic instructions. Researchers study how they communicate with the rest of the cell.

The cited work links MOTS-c to responses during exercise and stress. Animal performance findings are distinct from human observations. They do not establish an exercise replacement or a longevity treatment.

How does MOTS-c work in research models?

AMPK is a protein that helps cells sense their energy state. Researchers study how MOTS-c influences this pathway. AICAR is an intermediate molecule linked to AMPK signaling.

The proposed pathway involves the folate cycle, a set of chemical reactions in cells. Under stress, MOTS-c has also been studied in the nucleus. The nucleus contains most of a cell’s genetic information.

Retrograde signaling means communication from mitochondria back to the nucleus. Changes in gene activity may help explain model-specific responses. They do not prove a longer human lifespan.

The MOTS-c Signaling Cascade

Mitochondrial Encoding & Export

The genetic sequence associated with MOTS-c lies in mitochondrial DNA. Researchers study how the peptide is produced and distributed.

Folate Cycle Disruption

The folate cycle is a group of chemical reactions in cells. MOTS-c studies examine changes in this cycle.

Purine Biosynthesis Block

Purines are components used to build genetic material. AICAR can accumulate when related metabolic reactions change.

AMPK Activation

AMPK helps cells sense energy availability. Experiments link MOTS-c responses to activity in this pathway.

Nuclear Translocation

Translocation means movement to a different part of a cell. Under stress, studies report movement of MOTS-c into the nucleus.

Metabolic Reprogramming

Studies measure glucose uptake, fat metabolism and stress responses. These experimental changes do not establish an exercise replacement.

The Exercise Mimetic: What the Research Shows

Exercise-mimetic means producing some responses that resemble those linked to exercise. It does not mean reproducing all of exercise. The term needs this limit when reading MOTS-c studies.

The cited Reynolds study includes human exercise observations and mouse experiments. An increase in natural peptide levels differs from testing an added preparation. Neither result proves that a research vial improves human performance.

11.9-Fold Exercise Induction

Healthy young men performing acute exercise on a stationary bicycle showed an 11.9-fold increase in skeletal muscle MOTS-c levels, with corresponding increases in circulating plasma levels. This confirmed MOTS-c as an exercise-responsive signal — the muscle's own mitokine.

Reynolds et al., Nature Communications, 2021

Restored Physical Capacity in Aged Mice

Late-life treatment (initiated at 23.5 months — equivalent to ~70 human years) with intermittent MOTS-c (3x/week) significantly improved physical performance in old mice, including running endurance and treadmill capacity, to levels approaching those of younger animals.

Reynolds et al., Nature Communications, 2021

Reversed Diet-Induced Obesity

MOTS-c treatment reversed high-fat-diet-induced obesity and insulin resistance in mice, normalizing glucose homeostasis and reducing fat accumulation — recapitulating the metabolic benefits of regular exercise.

Lee et al., Cell Metabolism, 2015

Improved Insulin Sensitivity

In skeletal muscle, MOTS-c activated AMPK and increased GLUT4 translocation, directly improving glucose uptake — the same mechanism through which exercise improves insulin sensitivity.

Lee et al., Cell Metabolism, 2015

Menopause Model Protection

In ovariectomized mice (a menopause model), MOTS-c reduced white adipose tissue accumulation, increased brown fat activation, and improved insulin sensitivity — countering the metabolic decline that accompanies estrogen loss.

Lu et al., 2019

Cardiac Protection in Diabetes

In 2025, researchers demonstrated that MOTS-c restored mitochondrial respiratory function in diabetic heart tissue, improved glucose homeostasis, and reduced left ventricular hypertrophy. This extended its potential beyond skeletal muscle to cardiovascular protection.

Pham et al., Frontiers in Physiology, 2025

MOTS-c and Aging: The Longevity Connection

Aging research asks whether MOTS-c levels relate to muscle function and energy use. A biomarker is a measurable feature associated with a biological state. An association does not establish cause.

Genetic variants and animal aging models generate hypotheses. They cannot establish a human lifespan effect. Sarcopenia means age-related loss of muscle mass and strength.

MOTS-c vs. Other Longevity & Metabolic Peptides

MOTS-c, Epithalon, SS-31 and NAD+ differ in structure and research targets. NAD+ is a coenzyme, not a peptide. SS-31 is studied in relation to mitochondrial membranes.

These distinctions help frame laboratory comparisons. Similar interest in aging does not make the materials interchangeable. No table can establish that a combination improves human longevity.

Property	MOTS-c	Epithalon	SS-31 (Elamipretide)	NAD+
Origin	Mitochondrial genome	Synthetic (pineal extract)	Synthetic tetrapeptide	Coenzyme (dinucleotide)
Primary Target	AMPK pathway	Telomerase activation	Cardiolipin stabilization	Sirtuin/PARP activation
Aging Mechanism	Metabolic homeostasis	Telomere maintenance	Mitochondrial membrane repair	Cellular energy & DNA repair
Exercise Connection	Direct — induced 11.9x by exercise	None established	Indirect — improves mito function	Exercise increases NAD+ levels
Muscle Effects	Improved capacity + anti-myostatin	None established	Improved mito respiration	Improved oxidative metabolism
Human Data	Limited (1 clinical trial)	Very limited	Multiple clinical trials (Barth syndrome)	Multiple clinical trials
Key Distinction	Only known exercise mimetic MDP	Only telomere-targeted peptide	Only cardiolipin-targeting peptide	Most abundant cellular cofactor

Current Challenges and Research Frontiers

Translating preclinical findings into human evidence remains a major challenge. A clinical analogue is a modified research candidate. Results for an analogue are not automatically results for native MOTS-c.

Future questions include stability, formulation and reproducibility. Researchers also need to test whether model findings predict human outcomes. An encouraging animal result is a starting point, not a confirmed application.

Frequently Asked Questions

What is MOTS-c?

How does MOTS-c work?

MOTS-c disrupts the folate-methionine cycle, which causes accumulation of AICAR — a natural AMPK activator. Activated AMPK then triggers a cascade of metabolic improvements: enhanced glucose uptake, increased fat oxidation, improved insulin sensitivity, and stress resistance. Under metabolic stress, MOTS-c also translocates to the nucleus to directly regulate gene expression.

Is MOTS-c truly an 'exercise pill'?

MOTS-c mimics some metabolic effects of exercise, such as better glucose use, endurance and AMPK activation. Exercise, however, triggers hundreds of coordinated changes that no single molecule can replicate. MOTS-c is best understood as a compound that activates a key exercise-responsive pathway, particularly promising for individuals with limited mobility.

Does MOTS-c decline with age?

Yes. MOTS-c levels in blood and tissue fall with age in humans and rodents. This parallels age-related declines in mitochondrial function, exercise capacity and metabolic flexibility. This decline is part of what makes exogenous MOTS-c supplementation an area of active research interest.

What is the connection between MOTS-c and Japanese longevity?

Genetic-variant research has examined possible links with longevity. An association is not proof of cause. It does not establish that adding MOTS-c extends human lifespan.

Has MOTS-c been tested in humans?

Human data is extremely limited. CohBar registered one clinical trial (NCT03998514) of MOTS-c analogs in healthy volunteers and people with obesity or fatty liver disease. Its results have not been publicly reported. The strong preclinical results have not yet been validated in controlled human trials.

Can MOTS-c be combined with other peptides?

Different pathway targets can generate combination research questions. A combination needs its own evidence. Separate studies do not establish safety or synergy.

References

[1] Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454.
[2] Reynolds JC, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline. Nature Communications. 2021;12(1):470.
[3] Pham T, et al. Mitochondria-derived peptide MOTS-c restores mitochondrial respiration in type 2 diabetic heart. Front Physiol. 2025;16:1602271.
[4] Kim SJ, et al. MOTS-c: an equal opportunity insulin sensitizer. J Mol Med. 2019;97(4):487-490.
[5] Fuku N, et al. The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity? Aging Cell. 2015;14(6):921-923.
[6] D'Souza RF, et al. Increased expression of MOTS-c in skeletal muscle of healthy aging men. Aging. 2020;12(6):5244-5258.
[7] Zhai D, et al. MOTS-c peptide increases survival and decreases bacterial load in mice with MRSA. Mol Immunol. 2017;92:151-160.